Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05124522 · ClinicalTrials.gov registry record · NA

A Health Action Process Approach Online Intervention for People With Multiple Sclerosis

A NA study of Multiple Sclerosis, sponsored by University of Illinois at Urbana-Champaign.

Active
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT05124522 is a NA study of Multiple Sclerosis that is active but no longer recruiting, run by University of Illinois at Urbana-Champaign. The registered enrollment target is 60 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05124522, a NA study of Multiple Sclerosis, is active but no longer recruiting, sponsored by University of Illinois at Urbana-Champaign.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to implement the person-centered internet-based Health Action Process Approach to promoting physical activity in people with Multiple Sclerosis (i.e., eHAPA-MS online intervention) and assess the intervention's effectiveness and adherence.

Conditions Studied

Interventions

  • BEHAVIORAL MSPA eClass

Study Locations (1)

Illinois

  • University of Illinois Urbana-Champaign - Champaign

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2021-10-25
Est. Completion 2026-12-31
Phase NA

What the Registry Record Tells You About NCT05124522

The ClinicalTrials.gov registry entry for NCT05124522 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (90% lower). The listed sponsor is University of Illinois at Urbana-Champaign, which has 129 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which MSPA eClass is the first listed.

NCT05124522 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT05124522 about?

NCT05124522 is a clinical study titled "A Health Action Process Approach Online Intervention for People With Multiple Sclerosis". The purpose of this study is to implement the person-centered internet-based Health Action Process Approach to promoting physical activity in people with Multiple Sclerosis (i.e., eHAPA-MS online intervention) and assess the intervention's effectiveness and adherence.

What is the current status of trial NCT05124522?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2021-10-25. Estimated completion is 2026-12-31.

What conditions does trial NCT05124522 study?

This clinical trial studies the following conditions: Multiple Sclerosis.

What interventions are being tested in trial NCT05124522?

The interventions under investigation include: MSPA eClass (BEHAVIORAL).

Who is sponsoring clinical trial NCT05124522?

This trial is sponsored by University of Illinois at Urbana-Champaign, which has 129 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05124522 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.